NUKLEARMEDIZIN-NUCLEAR MEDICINE is a prestigious journal published by Georg Thieme Verlag KG, focusing on pivotal advancements in the fields of Nuclear Medicine, Radiology, and Imaging. Established in 1959, this journal has served as a critical platform for disseminating innovative research, reviews, and clinical guidelines until its anticipated convergence in 2024. With an ISSN of 0029-5566 and an E-ISSN of 2567-6407, NUKLEARMEDIZIN is acknowledged in the academic community as a Q3 category journal within Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023, highlighting its ongoing contribution to the interdisciplinary dialogue in healthcare. Although the journal does not currently offer open access, it remains accessible to professionals and students through various academic databases, ensuring that cutting-edge knowledge in this growing field is shared widely. Researchers interested in the latest methods and technologies in Nuclear Medicine will find NUKLEARMEDIZIN a valuable resource for enhancing their work and understanding the complexities of modern imaging modalities.

ACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.

Revista Española de Medicina Nuclear e Imagen Molecular, published by Elsevier España SLU, stands as a vital resource in the field of Radiology, Nuclear Medicine, and Molecular Imaging. With an ISSN of 2253-654X, this journal is committed to disseminating high-quality research and advancements in clinical practices, aiming to bridge the gap between theoretical research and application in healthcare. Operating since 2012, it features a robust archive of peer-reviewed articles and case studies, although it currently holds a Q4 ranking in the Scopus category, indicating significant potential for growth and influence within the academic community. The journal is indexed in Scopus, with a rank of 255 out of 333, placing it in the 23rd percentile, which underlines the need for increased contributions from researchers eager to enhance its standing. While it is not an open-access journal, its availability through libraries and institutions ensures that a wide audience can access critical findings and innovations in the rapidly evolving field of nuclear medicine. As we look towards the convergence period from 2012 to 2024, Revista Española de Medicina Nuclear e Imagen Molecular aspires to fortify its role as a cornerstone for collaboration and advancement in nuclear imaging and radiology.

The European Journal of Nuclear Medicine and Molecular Imaging is a prestigious, peer-reviewed journal published by Springer, dedicated to advancing the field of nuclear medicine and molecular imaging. With an impressive impact factor and ranked in the Q1 category for both Medicine and Radiology, Nuclear Medicine and Imaging, this journal is a pivotal platform for researchers and practitioners to disseminate significant findings from 1996 to the present, reflecting the evolution of the field. The journal boasts a notable Scopus rank, standing at #8 out of 333 in its category, placing it in the top 3% of published works, which highlights its critical importance in shaping contemporary practices and research innovations. Although it does not offer an open-access model, the journal provides various access options to ensure that important research is accessible to professionals, students, and academics alike. Through rigorous peer review and a commitment to high-quality publication, the European Journal of Nuclear Medicine and Molecular Imaging plays an essential role in the advancement of nuclear medicine, contributing to better diagnostic and therapeutic outcomes globally.

Abdominal Radiology is an esteemed journal published by Springer, focusing on the intricate and evolving field of abdominal imaging. With its ISSN 2366-004X and E-ISSN 2366-0058, this journal serves as a vital platform for disseminating high-quality research and clinical findings that advance both the understanding and practice of radiology specifically related to abdominal diseases. With a commendable impact, categorized in 2023 as Q2 in the fields of Gastroenterology, Radiological and Ultrasound Technology, and Radiology, Nuclear Medicine and Imaging, and Q1 in Urology, it attracts an audience eager for cutting-edge insights. Furthermore, its ranking in Scopus reflects its strong influence, with a notable position of #21 in Urology and #92 in Radiology. The journal adopts an Open Access model, facilitating a wider dissemination of knowledge and promoting collaborative research efforts on a global scale. The convergence of contributions from established researchers and emerging professionals alike enriches its content from 2016 to 2024, ensuring that readers remain at the forefront of abdominal diagnostics and therapeutic advancements.

PET Clinics, published by Elsevier Inc, is a premier academic journal focusing on the advancements and applications of Positron Emission Tomography (PET) in various medical fields. With its ISSN 1556-8598 and E-ISSN 1559-7814, the journal has established a strong reputation in the scientific community, reflected in its impressive Q1 quartile rankings in Medicine (miscellaneous), Radiation, and Radiology, Nuclear Medicine, and Imaging for 2023. The journal operates within a well-defined scope that bridges innovative research and practical clinical applications, targeting professionals, researchers, and students keen on the intersection of nuclear medicine and imaging technologies. Although not an open-access journal, PET Clinics ensures accessibility through institutional subscriptions, making valuable insights available to the academic community. With an emphasis on enhancing patient care and treatment outcomes through cutting-edge imaging techniques, this journal serves as an essential resource for those seeking to expand their knowledge and expertise in the rapidly evolving field of PET.

EJNMMI Research, a prominent journal published by Springer, plays a pivotal role in advancing the fields of radiology, nuclear medicine, and imaging. With an impact factor that reflects its strong standing—ranking in the top 22% of its category (Q1 as of 2023)—this open-access journal offers researchers, professionals, and students unparalleled access to innovative research and developments in the field since its inception in 2011. Based in Germany, EJNMMI Research fosters global collaboration by ensuring that cutting-edge findings are freely accessible, thereby accelerating scientific discovery and application. With an emphasis on high-quality, peer-reviewed articles, it serves as an essential resource for those seeking to stay at the forefront of nuclear medicine and imaging. By bridging theoretical insights with practical applications, the journal not only influences academic discourse but also supports ongoing advancements in clinical practices.

The Hellenic Journal of Nuclear Medicine, published by the Hellenic Society of Nuclear Medicine, serves as a pivotal platform for researchers, professionals, and students in the fields of nuclear medicine, radiology, and imaging. Based in Greece and established as a prominent forum since 2004, this journal is dedicated to advancing the understanding and application of nuclear medicine through high-quality original research, reviews, and clinical studies. With an ISSN of 1108-1430 and an E-ISSN of 1790-5427, it has garnered attention within its community, holding a Q3 ranking in the 2023 category of Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging. Despite its current Scopus ranking of #235/333 in the respective fields, the journal is increasingly recognized for its potential to contribute impactful knowledge and innovations. Researchers are encouraged to utilize its resources to enhance their work and contribute to the growing body of knowledge in nuclear medicine. Notably, the journal maintains a commitment to accessible scholarly communication, fostering collaboration among experts across the globe.

NUCLEAR MEDICINE AND BIOLOGY, published by Elsevier Science Inc, is a premier journal dedicated to advancing the fields of nuclear medicine and molecular biology. Since its inception in 1986, this journal has served as a vital platform for the dissemination of high-quality research, with a clear focus on the innovative applications of nuclear techniques in biological settings. It is categorized in the Q3 tier for both Cancer Research and Molecular Medicine, and Q2 for Radiology, Nuclear Medicine and Imaging, highlighting its significant standing within these disciplines. The journal's Scopus rankings reflect its strong impact, placing it in the top quartile of its categories, particularly in Radiology, Nuclear Medicine, and Imaging. Researchers, professionals, and students alike will find this an invaluable resource for contemporary research findings and methodologies in nuclear medicine and its biological applications. Access to the journal is provided through subscription, ensuring that quality content remains available to its wide-ranging audience.

NMR in Biomedicine is a prestigious journal published by Wiley that has been at the forefront of advancing research in the integration of Nuclear Magnetic Resonance (NMR) techniques within the realms of biomedicine since its establishment in 1988. With its ISSN 0952-3480 and E-ISSN 1099-1492, this journal focuses on the application of NMR across various scientific disciplines, including Molecular Medicine, Radiology, Nuclear Medicine and Imaging, and Spectroscopy. The journal is classified in the Q1 and Q2 quartiles as of 2023, showcasing its significant impact and contribution, particularly in Radiology and Spectroscopy, where it ranks in the top tier of its fields. The Scopus ranks reflect its esteemed position, with notable placements such as #70/333 in Radiology and #25/76 in Chemistry Spectroscopy. While Open Access options are not available, the journal remains committed to providing high-quality, peer-reviewed research that fosters innovation and collaboration within the scientific community. Researchers, professionals, and students are encouraged to explore the cutting-edge findings presented in this journal, as it continues to shape the future of biomedical applications of NMR.